Filing Flows › Lifecore Biomedical (LFCR) › CDMO revenue
Lifecore Biomedical (LFCR) CDMO revenue by quarter
Lifecore Biomedical's CDMO revenue was $17.8M in Q1 FY27 (first quarter fiscal 2027), +14% from Q1 FY27. Over the last 7 quarters it ranged from $15.6M (Q1 FY27) to $25.6M (Q2 FY25).
| Quarter | CDMO revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $17.8M | +14% | -18% |
| Q1 FY27 | $15.6M | -1% | -28% |
| Q3 FY26 | $15.8M | -27% | -24% |
| Q1 FY26 | $21.7M | -8% | — |
| Q4 FY25 | $23.5M | +13% | — |
| Q3 FY25 | $20.8M | -19% | — |
| Q2 FY25 | $25.6M | — | — |
Q1 FY27 at a glance
Lifecore Biomedical, Q1 FY27: revenue $25.3M (-19% year over year), operating margin -3.5%, net loss $40.1M, operating cash flow $6.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Lifecore Biomedical's CDMO revenue?
Lifecore Biomedical's CDMO revenue was $17.8M in Q1 FY27 (first quarter fiscal 2027), +14% from Q1 FY27.
How has Lifecore Biomedical's CDMO revenue changed?
Over the last 7 quarters it ranged from $15.6M (Q1 FY27) to $25.6M (Q2 FY25).